Modeling Stress-precipitated Smoking Behavior for Medication Development

What is the purpose of this trial?

To examine whether guanfacine, a noradrenergic agent, shown to be effective in improving stress-induced decrements in self-control using pre-clinical models, will attenuate stress-induced reinstatement to drug use and will attenutate the ability of stress to precipitate smoking lapse behavior

Participation Guidelines

Ages: 18 - 60 years

Gender: Both

National Institute on Drug Abuse

Start Date: 09/27/2008

End Date: 07/31/2017

Last Updated: 02/22/2018

Study HIC#: 0808004163

Get Involved

For more information about this study, contact:
Meaghan E. Lavery
+1 203-737-2783

If you would prefer to contact a member of the Help us Discover team about this trial and other similar trials, please email or call 1-877-978-8348.

Trial Image